logo

For the Inventor, By the Inventor

Rockville, MD, United States of America

Theriva Biologics, Inc.

Calculating rank
USPTO Granted Patents = 13


Forward Citations = 1

Loading Chart...
Loading Chart...

11 inventors (with patents filed for the assignee):

goldMedal Michael Kaleko (12 out of 63 patents)

silverMedal Christian Furlan Freguia (6 out of 9 patents)

bronzeMedal Sheila Connelly (6 out of 32 patents)

4.  Andrew Bristol (4 out of 10 patents)

5.  Steven Hubert (3 out of 6 patents)

6.  Vincent Wacher (3 out of 8 patents)

7.  J Blair West (2 out of 3 patents)

8.  Ray Stapleton (2 out of 3 patents)

9.  James Gubbins (2 out of 2 patents)

10.  Cristina Freire (2 out of 2 patents)

11.  Joseph Sliman (1 out of 3 patents)

12.  Marcel Van Den Brink (9 patents)

13.  Jonathan Peled (0 patent)

14.  Marina Burgos Da Silva (0 patent)

15.  Vincent John Wacher (0 patent)


13 patents:

1. 12508304 - ALKALINE PHOSPHATASE FORMULATIONS (2025-12-30),
2. 12472147 - INTESTINAL ALKALINE PHOSPHATASE FORMULATIONS (2025-11-18),
3. 12318434 - Alkaline phosphate-based oncology treatments (2025-06-03),
4. 12274740 - Microbiome protection from oral antibiotics (2025-04-14),
5. 12178917 - Beta-lactamase formulations and uses thereof (2024-12-31),
6. 12048735 - Alkaline phosphatase formulations (2024-07-30),
7. 11981899 - -based production of beta-lactamase (2024-05-14),
8. 11944669 - Method and compositions for inhibiting or preventing adverse effects of oral antibiotics (2024-04-02),
9. 11883474 - Microbiome protection from oral antibiotics (2024-01-30),
10. 11872268 - Safe and effective beta-lactamase dosing for microbiome protection (2024-01-16),
11. 11654184 - Alkaline phosphatase agents for treatment of radiation disorders (2023-05-23),
12. 11638699 - Intestinal alkaline phosphatase formulations (2023-05-02),
13. 11608494 - Beta-lactamases with improved properties for therapy (2023-03-21),
Company Overview
Theriva Biologics, Inc. is a biotechnology company based in Rockville, Maryland, specializing in the development of innovative therapies for cancer and other serious diseases. The company focuses on leveraging its proprietary platform to create biologics that target the tumor microenvironment, enhancing the efficacy of existing treatments. With a commitment to advancing therapeutic options, Theriva aims to improve patient outcomes through its cutting-edge research and development efforts in the field of oncology.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

13 Patents

#52 in Rockville, MD

#331 in Maryland

#23,863 in US

#45,104 in the World

Rockville, MD (US)
Rockville, MD, United States of America

Theriva Biologics, Inc.

Forward Citations = 1

11 inventors:

goldMedal Michael Kaleko (12 out of 63 patents)

silverMedal Christian Furlan Freguia (6 out of 9 patents)

bronzeMedal Sheila Connelly (6 out of 32 patents)

4.  Andrew Bristol (4 out of 10 patents)

5.  Steven Hubert (3 out of 6 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Theriva Biologics, Inc.. Retrieved from https://idiyas.com/company/theriva-biologics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…